Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03934710 · ClinicalTrials.gov registry record · Phase 1
Mood Effects of Serotonin Agonists Extended
A Phase 1 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT03934710 is a Phase 1 study that has completed, run by University of Chicago. The registered enrollment target is 56 participants.
The verdict
NCT03934710, a Phase 1 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
In this study we are examining the effects of repeated very low doses of serotonin agonists on mood individuals with negative mood.
Interventions
- DRUG Placebo
- DRUG Serotonin agonist - 13ug
- DRUG Serotonin agonist - 26ug
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2019-04-20 |
| Est. Completion | 2021-06-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03934710
The ClinicalTrials.gov registry entry for NCT03934710 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03934710 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03934710 about?
NCT03934710 is a clinical study titled "Mood Effects of Serotonin Agonists Extended". In this study we are examining the effects of repeated very low doses of serotonin agonists on mood individuals with negative mood.
What is the current status of trial NCT03934710?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2019-04-20. Estimated completion is 2021-06-07.
What interventions are being tested in trial NCT03934710?
The interventions under investigation include: Placebo (DRUG), Serotonin agonist - 13ug (DRUG), Serotonin agonist - 26ug (DRUG).
Who is sponsoring clinical trial NCT03934710?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.